Effect of ABO blood group on asymptomatic, uncomplicated and placental Plasmodium falciparum infection: systematic review and meta-analysis.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
25 Jan 2019
Historique:
received: 02 07 2018
accepted: 15 01 2019
entrez: 27 1 2019
pubmed: 27 1 2019
medline: 8 3 2019
Statut: epublish

Résumé

Malaria clinical outcomes vary by erythrocyte characteristics, including ABO blood group, but the effect of ABO blood group on asymptomatic, uncomplicated and placental Plasmodium falciparum (P. falciparum) infection remains unclear. We explored effects of ABO blood group on asymptomatic, uncomplicated and placental falciparum infection in the published literature. A systematic review and meta-analysis was performed using the preferred reporting items for systematic reviews and meta-analyses guidelines. Articles in Pubmed, Embase, Web of Science, CINAHL and Cochrane Library published before February 04, 2017 were searched without restriction. Studies were included if they reported P. falciparum infection incidence or prevalence, stratified by ABO blood group. Of 1923 articles obtained from the five databases (Embase = 728, PubMed = 620, Web of Science = 549, CINAHL = 14, Cochrane Library = 12), 42 met criteria for systematic review and 37 for meta-analysis. Most studies (n = 30) were cross-sectional, seven were prospective cohort, and five were case-control studies. Meta-analysis showed similar odds of uncomplicated P. falciparum infection among individuals with blood group A (summary odds ratio [OR] 0.96, 15 studies), B (OR 0.89, 15 studies), AB (OR 0.85, 10 studies) and non-O (OR 0.95, 17 studies) as compared to those with blood group O. Meta-analysis of four cohort studies also showed similar risk of uncomplicated P. falciparum infection among individuals with blood group non-O and those with blood group O (summary relative risk [RR] 1.03). Meta-analysis of six studies showed similar odds of asymptomatic P. falciparum infection among individuals with blood group A (OR 1.05), B (OR 1.03), AB (OR 1.23), and non-O (OR 1.07) when compared to those with blood group O. However, odds of active placental P. falciparum infection was significantly lower in primiparous women with non-O blood groups (OR 0.46, 95% confidence interval [CI] 0.23 - 0.69, I This study suggests that ABO blood group may not affect susceptibility to asymptomatic and/or uncomplicated P. falciparum infection. However, blood group O primiparous women appear to be more susceptible to active placental P. falciparum infection.

Sections du résumé

BACKGROUND BACKGROUND
Malaria clinical outcomes vary by erythrocyte characteristics, including ABO blood group, but the effect of ABO blood group on asymptomatic, uncomplicated and placental Plasmodium falciparum (P. falciparum) infection remains unclear. We explored effects of ABO blood group on asymptomatic, uncomplicated and placental falciparum infection in the published literature.
METHODS METHODS
A systematic review and meta-analysis was performed using the preferred reporting items for systematic reviews and meta-analyses guidelines. Articles in Pubmed, Embase, Web of Science, CINAHL and Cochrane Library published before February 04, 2017 were searched without restriction. Studies were included if they reported P. falciparum infection incidence or prevalence, stratified by ABO blood group.
RESULTS RESULTS
Of 1923 articles obtained from the five databases (Embase = 728, PubMed = 620, Web of Science = 549, CINAHL = 14, Cochrane Library = 12), 42 met criteria for systematic review and 37 for meta-analysis. Most studies (n = 30) were cross-sectional, seven were prospective cohort, and five were case-control studies. Meta-analysis showed similar odds of uncomplicated P. falciparum infection among individuals with blood group A (summary odds ratio [OR] 0.96, 15 studies), B (OR 0.89, 15 studies), AB (OR 0.85, 10 studies) and non-O (OR 0.95, 17 studies) as compared to those with blood group O. Meta-analysis of four cohort studies also showed similar risk of uncomplicated P. falciparum infection among individuals with blood group non-O and those with blood group O (summary relative risk [RR] 1.03). Meta-analysis of six studies showed similar odds of asymptomatic P. falciparum infection among individuals with blood group A (OR 1.05), B (OR 1.03), AB (OR 1.23), and non-O (OR 1.07) when compared to those with blood group O. However, odds of active placental P. falciparum infection was significantly lower in primiparous women with non-O blood groups (OR 0.46, 95% confidence interval [CI] 0.23 - 0.69, I
CONCLUSIONS CONCLUSIONS
This study suggests that ABO blood group may not affect susceptibility to asymptomatic and/or uncomplicated P. falciparum infection. However, blood group O primiparous women appear to be more susceptible to active placental P. falciparum infection.

Identifiants

pubmed: 30683058
doi: 10.1186/s12879-019-3730-z
pii: 10.1186/s12879-019-3730-z
pmc: PMC6346527
doi:

Substances chimiques

ABO Blood-Group System 0

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

86

Références

Malar J. 2011 Oct 19;10:309
pubmed: 22011404
Asian Pac J Trop Biomed. 2011 Aug;1(4):289-94
pubmed: 23569777
Mcgill J Med. 2006 Jan;9(1):8-13
pubmed: 19529802
Indian J Malariol. 1995 Jun;32(2):59-63
pubmed: 7589729
J Vector Borne Dis. 2012 Jun;49(2):78-81
pubmed: 22898478
N Engl J Med. 2014 Jun 5;370(23):2211-8
pubmed: 24897084
J Vector Borne Dis. 2013 Dec;50(4):292-6
pubmed: 24499852
Malar J. 2013 May 24;12:169
pubmed: 23706132
Malar J. 2012 Jan 31;11:29
pubmed: 22289302
Malar J. 2014 Jul 28;13:289
pubmed: 25066505
Lancet Infect Dis. 2007 Feb;7(2):105-17
pubmed: 17251081
Adv Parasitol. 2007;65:1-50
pubmed: 18063095
Malar J. 2015 Sep 05;14:341
pubmed: 26341782
J Med Entomol. 2004 Jul;41(4):796-9
pubmed: 15311477
Microbes Infect. 2006 Aug;8(9-10):2352-8
pubmed: 16859949
Genet Mol Res. 2010 Jul 27;9(3):1443-9
pubmed: 20677133
BMC Med. 2016 Sep 19;14(1):142
pubmed: 27645498
Indian J Malariol. 1992 Dec;29(4):235-9
pubmed: 1291344
PLoS Negl Trop Dis. 2016 Dec 7;10(12):e0005193
pubmed: 27926919
Malar J. 2017 Oct 5;16(1):400
pubmed: 28982374
Contemp Clin Trials. 2007 Feb;28(2):105-14
pubmed: 16807131
Mediterr J Hematol Infect Dis. 2012;4(1):e2012026
pubmed: 22708041
Acta Trop. 2012 Sep;123(3):164-9
pubmed: 22569530
J Parasitol. 2009 Jun;95(3):751-2
pubmed: 19642807
J Parasit Dis. 2012 Apr;36(1):1-6
pubmed: 23542574
PLoS One. 2019 Jan 24;14(1):e0211205
pubmed: 30677102
Malar J. 2013 Apr 24;12:139
pubmed: 23617626
Acta Trop. 2012 Aug;123(2):72-7
pubmed: 22503377
Expert Rev Anti Infect Ther. 2013 Jun;11(6):623-39
pubmed: 23750733
Proc Natl Acad Sci U S A. 2007 Oct 30;104(44):17471-6
pubmed: 17959777
BMC Med. 2015 Mar 03;13:42
pubmed: 25858094
Indian J Malariol. 1992 Dec;29(4):241-4
pubmed: 1291345
Parasit Vectors. 2016 Jun 15;9(1):344
pubmed: 27306987
Blood. 2007 Oct 1;110(7):2250-8
pubmed: 17502454
J Epidemiol. 2005 Nov;15(6):235-43
pubmed: 16276033
Genes Immun. 2000 Oct;1(7):435-41
pubmed: 11196674
Lancet Infect Dis. 2012 Jun;12(6):457-68
pubmed: 22445352
Malar J. 2006 Aug 17;5:72
pubmed: 16916459
Malar J. 2007 Aug 10;6:110
pubmed: 17692119
Clin Infect Dis. 2003 May 1;36(9):1198-202
pubmed: 12715318
Malar J. 2010 Oct 12;9:280
pubmed: 20939876
Syst Rev. 2013 Jan 15;2:4
pubmed: 23320413
Am J Surg Pathol. 1998 Aug;22(8):1006-11
pubmed: 9706981
Indian J Malariol. 1987 Jun;24(1):33-8
pubmed: 3481577
J Commun Dis. 1992 Dec;24(4):199-205
pubmed: 1344953
Trans R Soc Trop Med Hyg. 2000 Apr;94 Suppl 1:S1-90
pubmed: 11103309
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563
Nat Rev Microbiol. 2017 Aug;15(8):479-491
pubmed: 28603279
Nature. 1972 Sep 15;239(5368):165
pubmed: 4561964
Vox Sang. 2011 Jan;100(1):99-111
pubmed: 21175660
J Eval Clin Pract. 2008 Oct;14(5):951-7
pubmed: 19018930
Hum Biol. 2006 Apr;78(2):215-9
pubmed: 17036927
BMC Infect Dis. 2009 Nov 20;9:180
pubmed: 19930552
PLoS One. 2017 Oct 13;12(10):e0186577
pubmed: 29028827
Am J Trop Med Hyg. 2012 Sep;87(3):447-449
pubmed: 22826494
Infect Dis Poverty. 2016 Jun 09;5(1):61
pubmed: 27282148
PLoS One. 2012;7(11):e49420
pubmed: 23152904
BMC Infect Dis. 2012 Nov 09;12:291
pubmed: 23136960
JAMA. 2015 Apr 28;313(16):1657-65
pubmed: 25919529
BMC Med. 2015 Feb 03;13:23
pubmed: 25644195
Blood Rev. 2019 Jan;33:53-62
pubmed: 30029997
Diagn Pathol. 2015 May 06;10:49
pubmed: 25943348
Trans R Soc Trop Med Hyg. 2000 Nov-Dec;94(6):645-51
pubmed: 11198648
Malar J. 2007 Aug 03;6:102
pubmed: 17683546
Ann Trop Med Parasitol. 2005 Mar;99(2):119-24
pubmed: 15814030
Nat Med. 2015 Apr;21(4):314-7
pubmed: 25751816
PLoS One. 2015 Dec 29;10(12):e0145120
pubmed: 26714011
J Vector Borne Dis. 2010 Mar;47(1):11-6
pubmed: 20231768
Malar J. 2008 Jan 03;7:1
pubmed: 18173836
Tanzan Health Res Bull. 2007 Sep;9(3):180-5
pubmed: 18087896
Malar J. 2011 Apr 22;10:101
pubmed: 21513504
Malar Res Treat. 2016;2016:8043768
pubmed: 26925291
Malar J. 2011 Sep 19;10:271
pubmed: 21929748
Indian J Malariol. 1997 Mar;34(1):42-6
pubmed: 9291673
Acta Trop. 1982 Jun;39(2):179-84
pubmed: 6126100
Infect Dis Rep. 2011 Dec 16;3(2):e16
pubmed: 24470913

Auteurs

Abraham Degarege (A)

Department of Epidemiology, Robert Stempel College of Public Health & Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA. ameng002@fiu.edu.
Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia. ameng002@fiu.edu.

Merhawi T Gebrezgi (MT)

Department of Epidemiology, Robert Stempel College of Public Health & Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA.

Consuelo M Beck-Sague (CM)

Department of Health Promotion and Disease Prevention, Robert Stempel College of Public Health & Social Work, Florida International University, Miami, Florida, USA.

Mats Wahlgren (M)

Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institute, Stockholm, Sweden.

Luiz Carlos de Mattos (LC)

Molecular Biology Department, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto, SP, Brazil.

Purnima Madhivanan (P)

Department of Epidemiology, Robert Stempel College of Public Health & Social Work, Florida International University, 11200 SW 8th Street, Miami, FL, 33199, USA.
Public Health Research Institute of India, Mysore, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH